Drugs / SSR97225
last change Aug 2008 re-read 3 minutes ago

SSR97225

Developed for
neoplasm
Investigated by
Sanofi

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00547261 Oct 2007 → Aug 2008 neoplasm Sanofi Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SSR97225 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00547261 ↗
Route Intravenous “1 hour IV infusion D1” NCT00547261 ↗